Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank

BACKGROUND: Mildly elevated bilirubin, a by-product of hemoglobin breakdown, might mitigate cardiometabolic risk factors including adiposity, dyslipidemia, and high blood pressure (BP). We investigated the cross-sectional relationship between (total) bilirubin and baseline cardiometabolic risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyed Khoei, Nazlisadat, Wagner, Karl-Heinz, Sedlmeier, Anja M., Gunter, Marc J., Murphy, Neil, Freisling, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017025/
https://www.ncbi.nlm.nih.gov/pubmed/35436955
http://dx.doi.org/10.1186/s12933-022-01484-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017025/
https://www.ncbi.nlm.nih.gov/pubmed/35436955
http://dx.doi.org/10.1186/s12933-022-01484-x

Ejemplares similares